A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease
<p>Abstract</p> <p>Classical non-insulin antihyperglycemic drugs currently approved for the treatment of type 2 diabetes mellitus (T2DM) comprise five groups: biguanides, sulfonylureas, meglitinides, glitazones and alpha-glucosidase inhibitors. Novel compounds are represented by th...
Main Authors: | Fisman Enrique Z, Tenenbaum Alexander |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-07-01
|
Series: | Cardiovascular Diabetology |
Online Access: | http://www.cardiab.com/content/8/1/38 |
Similar Items
-
Omega-3 polyunsaturated fatty acids supplementation in patients with diabetes and cardiovascular disease risk: does dose really matter?
by: Alexander Tenenbaum, et al.
Published: (2018-08-01) -
5 YEARS WITH RATIONAL PHARMACOTHERAPY IN CARDIOLOGY
Published: (2016-01-01) -
5 YEARS WITH RATIONAL PHARMACOTHERAPY IN CARDIOLOGY
Published: (2016-01-01) -
Evidence-based pharmacotherapy in cardiology. National guideline
by: S. Yu. Martsevich, et al.
Published: (2024-03-01) -
THE ROLE OF P-GLYCOPROTEIN IN RATIONAL PHARMACOTHERAPY IN CARDIOLOGY
by: A. V. Shulkin, et al.
Published: (2015-09-01)